Question 1

What is Black Diamond Therapeutics?

Accepted Answer

Black Diamond Therapeutics is a Company.

Question 2

How often does Black Diamond Therapeutics appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 12 articles.

Question 3

When was Black Diamond Therapeutics first tracked by Ergen?

Accepted Answer

First tracked on Apr 21, 2026.

Question 4

When was Black Diamond Therapeutics last mentioned in news?

Accepted Answer

Last active on May 21, 2026.

Question 5

What is Black Diamond Therapeutics's current news sentiment?

Accepted Answer

Aggregate sentiment score: 38 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Black Diamond Therapeutics in global news coverage?

Accepted Answer

Attention score of 6, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Black Diamond Therapeutics?

Accepted Answer

Black Diamond Therapeutics' Silevertinib Phase 2 Success (May 21, 2026, 6 articles).

Question 8

How did the "Black Diamond Therapeutics' Silevertinib Phase 2 Success" event impact Black Diamond Therapeutics?

Accepted Answer

Black Diamond Therapeutics announced positive Phase 2 trial results for Silevertinib, which is expected to significantly boost its stock price and market position in oncology.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.